• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 36 of 100
AstraZeneca Gilead deal
HealthRumors swirl about an AstraZeneca and Gilead megadeal—but it doesn’t make sense
By Sy MukherjeeJune 8, 2020
5 companies to keep an eye on following the world’s largest cancer conference
Health5 companies to keep an eye on following the world’s largest cancer conference
By Sy MukherjeeJune 3, 2020
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
FinanceFrance’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
By James Paton, Riley Griffin and BloombergMay 26, 2020
Hydroxychloroquine study shows deaths, heart risks in COVID-19 patients
HealthHydroxychloroquine linked to deaths and heart risks in new COVID-19 study after Trump touted and claimed to be taking the drug
By John Lauerman and BloombergMay 22, 2020
Moderna Therapeutics coronavirus vaccine
NewslettersModerna’s coronavirus vaccine expectations game
By Sy MukherjeeMay 21, 2020
Tobacco giants are getting into the coronavirus vaccine race
HealthTobacco giants are getting into the coronavirus vaccine race
By Sy MukherjeeMay 21, 2020
Moderna coronavirus vaccine trial
HealthModerna releases promising—but early—new coronavirus vaccine data
By Sy MukherjeeMay 18, 2020
ZOE.07.20.Kristin-Peck
MagazineThe CEO who keeps animal pharm growing
By Anne SradersMay 16, 2020
Antibody testing will be key—once we understand what the results mean
HealthAntibody testing will be key—once we understand what the results mean
By Sy MukherjeeMay 12, 2020
Gilead remdesivir price
NewslettersGilead’s moral (and financial) COVID-19 conundrum
By Sy MukherjeeMay 7, 2020
Gilead-Sciences-Remdesivir
HealthRemdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?
By Sy MukherjeeMay 1, 2020
COVID forgotten communities
NewslettersThe communities we forget during COVID-19
By Sy MukherjeeApril 30, 2020
Gilead remdesivir coronavirus FDA
HealthGilead’s remdesivir won’t be a COVID-19 miracle cure, but it’s still an important first step
By Sy MukherjeeApril 30, 2020
The coronavirus pandemic is impacting critical research into neuromuscular diseases
HealthThe coronavirus pandemic is impacting critical research into neuromuscular diseases
By Sy MukherjeeApril 28, 2020
People observing social distancing rules while waiting in line outside a Walgreens Pharmacy in New York City.
TechHow a pharmacy delivery startup has capitalized on the coronavirus pandemic
By Jeremy KahnApril 21, 2020
1...
  • 34
  • 35
  • 36
  • 37
  • 38
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
A 93-year-old refused to sell her home to the Masters golf course that’s spent $280 million on expansion: ‘Money ain’t everything’placeholder alt text
By Fortune EditorsApril 12, 2026
Economy
'People are trying to be creative': Tariff-battered American companies are so cash-starved they are using refund claims as collateral for loansplaceholder alt text
By Fortune EditorsApril 12, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.